Figure 8.
Molecular characteristics of IGSPP subgroups. (A, B) GSEA enrichment analysis in the IGSPP high-risk group (p < 0.05). (C) GSEA enrichment analysis in the IGSPP low-risk group (p < 0.05). (D) Gene mutations of patients within the IGSPP high-risk group. (E) Gene mutations of patients within the IGSPP low-risk group. (F) Correlation between the TMB and IGSPP score. (G) Correlation between the TMB and OS in patients with LUAD.